Harboyan syndrome
MeSH: C535473ORPHA: 14903 Treatments Available
Overview
human disease
Available Treatments (3)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Dorzolamide | Ophthalmic solution, 2% | FDA Approved | 7 | 7d |
| Hypertonic saline | Ophthalmic solution, 5%; Ophthalmic ointment, 5% | FDA Approved | 7 | 3d |
| Timolol maleate | Ophthalmic solution, 0.25%, 0.5% | FDA Approved | 8 | 5d |
Clinical Presentation
Signs and symptoms associated with Harboyan syndrome, sourced from HPO and Orphanet clinical annotations.
Sensorineural hearing impairmentVisual impairmentNystagmusCorneal dystrophyCorneal opacity
Classification & Codes
MeSH Code
C535473Orphanet Code
ORPHA:1490Harboyan syndrome
| MeSH | C535473 |
| Orphanet | ORPHA:1490 |
| Treatments | 3 drug(s) |
| Symptoms on record | 5 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO